Literature DB >> 25109754

The long-term impact of diabetes on graft patency after coronary artery bypass grafting surgery: a substudy of the multicenter Radial Artery Patency Study.

Saswata Deb1, Steve K Singh2, Fuad Moussa3, Hideki Tsubota3, Dai Une4, Alex Kiss5, George Tomlinson6, Mehdi Afshar3, Ryan Sless3, Eric A Cohen3, Sam Radhakrishnan3, James Dubbin3, Leonard Schwartz7, Stephen E Fremes8.   

Abstract

OBJECTIVES: The study objective was to determine the impact of diabetes on radial artery and saphenous vein graft occlusion and clinical outcomes more than 5 years after coronary artery bypass surgery in the multicenter Radial Artery Patency Study (NCT00187356).
METHODS: A total of 529 patients aged less than 80 years with triple-vessel disease undergoing coronary bypass surgery participated in this study. Angiographic follow-up occurred more than 5 years after surgery with annual clinical follow-up. The primary objective was to compare the proportion of complete graft occlusion between radial artery and saphenous vein grafts among diabetic and nondiabetic persons. Additional objectives included determining predictors of complete graft occlusion and comparison of major adverse cardiac events defined by cardiac death, late myocardial infarction, and reintervention.
RESULTS: There were 148 of 529 patients (27.8%) with diabetes; 269 patients (83/269 [30.9%] diabetic) underwent late angiography at mean of 7.7±1.5 years after surgery. In diabetic patients, the proportion of complete graft occlusion was significantly lower in the radial grafts (4/83 [4.8%]) than in the saphenous grafts (21/83 [25.3%]) (P=.0004), and this was similar in nondiabetic patients (P=.19). Multivariate modeling showed that the use of the radial artery and high-grade target vessel stenosis were protective against late graft occlusion, whereas female gender, smoking history, and elevated creatinine were associated with an increased risk; interaction between diabetic status and conduit type also was significant (P=.02). Major adverse cardiac events were higher in diabetic patients (23/148 [15.5%] vs 35/381 [9.2%], P=.04).
CONCLUSIONS: The use of the radial artery should be strongly considered in diabetic patients undergoing coronary bypass surgery, especially with high-grade target vessel stenosis.
Copyright © 2014 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25109754     DOI: 10.1016/j.jtcvs.2014.06.057

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  10 in total

1.  Long term outcomes of radial artery grafting in patients undergoing coronary artery bypass surgery.

Authors:  James Tatoulis; Thomas A Schwann
Journal:  Ann Cardiothorac Surg       Date:  2018-09

Review 2.  Type 1 diabetes mellitus and coronary revascularization.

Authors:  Helene Mamet; Mark C Petrie; Paul Rocchiccioli
Journal:  Cardiovasc Endocrinol Metab       Date:  2019-02-13

3.  Short- and long-term results of radial artery and saphenous vein grafts in the right coronary system: a propensity-matched study.

Authors:  Shohei Yoshida; Satoshi Numata; Yasushi Tsutsumi; Osamu Monta; Sachiko Yamazaki; Hiroyuki Seo; Takaaki Samura; Hirokazu Ohashi
Journal:  Surg Today       Date:  2016-08-09       Impact factor: 2.549

4.  Long-term outcomes of multiple and single arterial off-pump coronary artery bypass grafting.

Authors:  Pengxiong Zhu; Anqing Chen; Zhe Wang; Xiaofeng Ye; Mi Zhou; Jun Liu; Qiang Zhao
Journal:  J Thorac Dis       Date:  2019-03       Impact factor: 2.895

5.  The radial artery is protective in women and men following coronary artery bypass grafting-a substudy of the radial artery patency study.

Authors:  Derrick Y Tam; Saswata Deb; Bao Nguyen; Dennis T Ko; Reena Karkhanis; Fuad Moussa; Jaclyn Fremes; Eric A Cohen; Sam Radhakrishnan; Stephen E Fremes
Journal:  Ann Cardiothorac Surg       Date:  2018-07

6.  The association between coronary graft patency and clinical status in patients with coronary artery disease.

Authors:  Mario Gaudino; Antonino Di Franco; Deepak L Bhatt; John H Alexander; Antonio Abbate; Lorenzo Azzalini; Sigrid Sandner; Garima Sharma; Sunil V Rao; Filippo Crea; Stephen E Fremes; Sripal Bangalore
Journal:  Eur Heart J       Date:  2021-04-07       Impact factor: 29.983

Review 7.  Can the onset of heart failure be delayed by treating diabetic cardiomyopathy?

Authors:  Anna Marcinkiewicz; Stanisław Ostrowski; Józef Drzewoski
Journal:  Diabetol Metab Syndr       Date:  2017-04-04       Impact factor: 3.320

8.  Assessing the Long-term Patency and Clinical Outcomes of Venous and Arterial Grafts Used in Coronary Artery Bypass Grafting: A Meta-analysis.

Authors:  Abdul Waheed; Emily Klosterman; Joseph Lee; Ankita Mishra; Vijay Narasimha; Faiz Tuma; Faran Bokhari; Furqan Haq; Subhasis Misra
Journal:  Cureus       Date:  2019-09-16

9.  Impact of Conventional Cardiovascular Risk Factors on Left Internal Mammary Artery Graft Disease.

Authors:  Hui-Juan Zuo; Nan Nan; Hong-Xia Yang; Jin-Wen Wang; Xian-Tao Song
Journal:  Front Cardiovasc Med       Date:  2022-01-14

10.  Advanced glycation end products impair the functions of saphenous vein but not thoracic artery smooth muscle cells through RAGE/MAPK signalling pathway in diabetes.

Authors:  Yongxin Sun; Le Kang; Jun Li; Huan Liu; Yulin Wang; Chunsheng Wang; Yunzeng Zou
Journal:  J Cell Mol Med       Date:  2016-06-14       Impact factor: 5.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.